Evaluation of the anti-diabetic drug sitagliptin as a novel attenuate to SARS-CoV-2 evidence-based in silico: molecular docking and molecular dynamics.

Autor: da Cruz Freire, José Ednésio1,2,3 (AUTHOR) jednesio@gmail.com, Júnior, José Edvar Monteiro4 (AUTHOR), Pinheiro, Daniel Pascoalino5 (AUTHOR), da Cruz Paiva Lima, Grayce Ellen1,2,3,6 (AUTHOR), do Amaral, Camila Lopes1,2,3 (AUTHOR), Veras, Victor Rezende1,2 (AUTHOR), Madeira, Mayara Ponte1,2,3,7 (AUTHOR), Freire, Erika Bastos Lima1,2,3,7 (AUTHOR), Ozório, Renan Galvão1,2 (AUTHOR), Fernandes, Virgínia Oliveira1,2,3,8 (AUTHOR), Montenegro, Ana Paula Dias Rangel1 (AUTHOR), Montenegro, Raquel Carvalho2 (AUTHOR), Colares, Jeová Keny Baima3 (AUTHOR), Júnior, Renan Magalhães Montenegro1,2,3,8 (AUTHOR)
Zdroj: 3 Biotech. 11/7/2022, Vol. 12 Issue 12, p1-13. 13p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje